Breaking news from ASCO Annual Meeting 2009

July 21, 2009 by Editor

Living Beyond Breast Cancer have both transcript and audio recording of Breaking News from the 2009 Annual Meeting of the American Society of Clinical Oncology with Virginia Kaklamani, MD, DSc (transcript, audio recording).

Get the latest news from the annual meeting of the American Society of Clinical Oncology. Dr. Kaklamani explains how tamoxifen works, its impact on cognitive function and why antidepressants may interfere with its effectiveness. Hear results from studies on lymph node metastases; combining bevacizumab (brand name: Avastin) with chemotherapy; diet; exercise; and vitamin D; and learn about a new targeted therapy for triple-negative breast cancer.

(Click on higlighted links in first paragraph to learn more)

Category : Conferences, Seminars, Public Information Sessions, Research

Tags : american society of clinical oncology, Avastin, bevacizumab, breast cancer research, chemotherapy, diet and cancer, exercise and cancer, lymph node metastes, tamoxifen and anti-depressants, tamoxifen and cognitive function, targeted cancer therapy, Triple-Negative Breast Cancer, virginia kaklamani, vitamin D and cancer

← Put down the stethoscope; listen to your patient

Avocado and Almond Facial Polish →

One thought on “Breaking news from ASCO Annual Meeting 2009”

Janine Guglielmino on July 21, 2009 at 6:55 pm said:

Thank you for letting people know about Living Beyond Breast Cancer’s resources! We’ve also posted several news stories on our home page, so please check them out. Thank you for all the work you do!

LikeLike

Reply ↓

	Marie Ennis-O'Connor… on Weekly Round-Up
	nancyspoint on Weekly Round-Up
	Marie Ennis-O'Connor… on Weekly Round-Up
	nancyspoint on Weekly Round-Up
	Julia on Weekly Round-Up

Journeying Beyond Breast Cancer